• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Emergency

Lower doses of ketamine shown to be non-inferior for acute pain control in the emergency setting

byBrian DoughertyandAlex Chan
December 29, 2020
in Emergency
Reading Time: 2 mins read
2 Minute Medicine Rewind October 14, 2019
Share on FacebookShare on TwitterShare on LinkedIn

1. For the treatment of acute pain in the emergency setting, 0.15 mg/kg IV ketamine was shown to be non-inferior to a higher dose of 0.3 mg/kg.

Evidence Level Rating: 1 (Excellent)

The opiate crisis has led many providers to search for new agents for analgesia; one such agent is ketamine, an N-methyl-D-aspartate (NMDA) glutamate receptor antagonist with analgesic properties. The most commonly used dose is 0.3 mg/kg IV, and carries with it side effects like dizziness, disorientation, and a “feeling of unreality.” This double-blinded, randomized, non-inferiority trial compared administration of 0.15 mg/kg IV with 0.3 mg/kg IV for analgesia at 30 minutes as measured by the 11-point NRS pain score. A previous, similar study determined the non-inferiority margin to be the minimally clinically relevant difference (δ=1.3), with the low dose being non-inferior if the lower limit of the 95% CI for the difference in mean NRS score after 30 minutes exceeded –𝛿0 = -1.3. 98 patients were enrolled in the emergency setting, 49 in the low dose cohort (mean [SD] age = 39 years, 39% male) and 49 in the high dose cohort (mean age = 37 years, 45% male). After 30 minutes, the unadjusted mean NRS score was 5.0 and 4.7 in the low and high dose cohorts, respectively. The mean NRS score difference was -0.3 (95% CI -1.6 to 1.0); thus, the non-inferiority of the low dose was confirmed. Furthermore, the incidence of hearing changes, mood alteration, and hallucinations was significantly higher in the high dose cohort early after administration, though these differences were no longer apparent at 30 minutes. In all, this study did not detect an appreciable difference in analgesia or side effect profile between 0.15 mg/kg and 0.3 mg/kg IV ketamine for treatment of acute pain in the emergency setting. This lower dose should therefore be considered over the higher dose for analgesia in the emergency department.

Click to read the study in SAEM

Image: PD

©2020 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

RELATED REPORTS

Emergency department triaging decisions supported by artificial intelligence (AI) led to improved triaging accuracy and patient flow

Epidural analgesia in labour is not associated with adverse neonatal health outcomes

A chemical denervation intervention may be safe and effective for pain management in avascular necrosis of the hip

Tags: analgesiaemergency medicinepain management
Previous Post

#VisualAbstract: Special Report: Vaccines in Development Part 2: Moderna vaccine second to receive emergency use authorization

Next Post

Adenovirus-vectored ChAdOx1 nCoV-19 vaccine offers a good safety profile and strong immunogenicity against COVID-19 in older adults 

RelatedReports

Artificial Intelligence

Emergency department triaging decisions supported by artificial intelligence (AI) led to improved triaging accuracy and patient flow

September 21, 2026
Behavioral dysregulation in infancy predicts later child mental health
Imaging and Intervention

Epidural analgesia in labour is not associated with adverse neonatal health outcomes

July 23, 2026
MRI screening may improve osteonecrosis outcomes in children with leukemia
Chronic Disease

A chemical denervation intervention may be safe and effective for pain management in avascular necrosis of the hip

July 16, 2026
Physical therapy reduces pain in adults with knee osteoarthritis
Chronic Disease

Selective serotonin reuptake inhibitors may reduce risk of total joint arthroplasty in osteoarthritis

May 21, 2026
Next Post
Medical vaccine exemptions increase after elimination of nonmedical exemptions

Adenovirus-vectored ChAdOx1 nCoV-19 vaccine offers a good safety profile and strong immunogenicity against COVID-19 in older adults 

#VisualAbstract: Special Report: Vaccines in Development Part 2: Moderna vaccine second to receive emergency use authorization

#VisualAbstract: Special Report: Vaccines in Development Part 3: Oxford/AstraZeneca vaccine showing promise

Fish oil and aspirin did not reduce arteriovenous fistula failure: The FAVOURED trail

Abnormal preoperative digital brachial index is associated with lower two-year arteriovenous fistula access patency

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

NPI Lookup · Free

Look up any US clinician

Search by name or NPI number, live from the CMS NPI Registry.

  • OIG exclusion check
  • Licenses and specialties
  • No account needed
Open NPI Lookup →

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Artificial intelligence (AI)-powered mental health app demonstrated improved social well-being among users
  • Children with intellectual and developmental disabilities have increased risks of depression and anxiety
  • Gabapentin (Neurontin) prescription for chronic low back pain in adults is associated with a higher risk of dementia
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
  • ✓NPI watchlist + bulk NPI verification

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.